Cipla Limited (NSEI:CIPLA) agreed to acquire Humalog and Trulicity from Eli Lilly and Company (India) Pvt. Ltd. on October 4, 2021. Lilly will continue to maintain its existing operating model for the remaining portfolio of products. The transaction is subject to all regulatory approvals